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In vivo evaluation of acellular human dermis for abdominal wall
repair
Abstract
Limitations of synthetic biomaterials for abdominal wall repair have led investigators to seek naturally
derived matrices, such as human acellular dermis, because of their excellent biocompatibility and their
ability to naturally interface with host tissues with minimal tissue response. In this study, we
investigated two different biomaterials derived from human dermis (FlexHD acellular dermis and
FlexHD acellular dermis-thick) in a rabbit abdominal hernia repair model. One quarter of the abdominal
wall was replaced with each biomaterial, and the animals were followed for up to 24 weeks. Rabbit
hernias repaired with AlloDerm(R), a commercially available acellular dermal matrix, and sham
operated animals served as controls. Retrieved samples of these implants were assessed grossly and
histologically. Collagen production measurements and tension studies were performed. FlexHD
acellular dermis, FlexHD acellular dermis-thick, and AlloDerm(R) maintained their strength in the
rabbit hernia repair model with no incidence of hernia formation or bowel adhesion. The exact size
measurements at 24 weeks were 217.0 +/- 20.9% for FlexHD acellular dermis, 200.8 +/- 23.5% for
FlexHD acellular dermis-thick, and 209.7 +/- 32.9% for AlloDerm(R). Macroscopic and microscopic
evaluation showed excellent integration and tissue formation. All biomaterials studied harbored cells
that produced new collagen fibers, and a six-fold increase in these fibers was observed at 24 weeks. This
study shows that acellular biomaterials derived from human dermis are suitable for abdominal hernia
repair. (c) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 2010.
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Abstract: 
 
Limitations of synthetic biomaterials for abdominal wall repair have led investigators to 
seek naturally derived matrices, such as human acellular dermis, because of their 
excellent biocompatibility and their ability to naturally interface with host tissues with 
minimal tissue response. In this study we investigated two different biomaterials derived 
from human dermis (FlexHD Acellular Dermis and FlexHD Acellular Dermis – THICK) in 
a rabbit abdominal hernia repair model. One quarter of the abdominal wall was replaced 
with each biomaterial, and the animals were followed for up to 24 weeks. Rabbit hernias 
repaired with AlloDerm®, a commercially available acellular dermal matrix, and sham 
operated animals served as controls. Retrieved samples of these implants were 
assessed grossly and histologically. Collagen production measurements and tension 
studies were performed. FlexHD Acellular Dermis, FlexHD Acellular Dermis – THICK, 
and AlloDerm® maintained their strength in the rabbit hernia repair model with no 
incidence of hernia formation or bowel adhesion. The exact size measurements at 24 
weeks were 217.0 ± 20.9% for FlexHD Acellular Dermis, 200.8 ± 23.5% for FlexHD 
Acellular Dermis – THICK, and 209.7 ± 32.9% for AlloDerm®. Macroscopic and 
microscopic evaluation showed excellent integration and tissue formation. All 
biomaterials studied harbored cells that produced new collagen fibers, and a 6-fold 
increase in these fibers was observed at 24 weeks. This study shows that acellular 
biomaterials derived from human dermis are suitable for abdominal hernia repair.   
 
 
Keywords: Acellular matrices, biomaterials, human dermis, hernia repair 
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Introduction 
Both synthetic implants and naturally derived tissue matrices have been used as 
biomaterials for abdominal wall repair1-5. Although synthetic materials, such as 
polypropylene mesh, are able to provide the required tensile strength to support 
abdominal viscera, this material is associated with untoward effects, including fibrotic 
encapsulation, infection, erosion and mesh extrusion, and these issues remain a 
problem 4,6-13. Increasingly, naturally derived processed tissue matrices, such as human 
acellular dermis, human dura and bovine pericardium, have been used because of their 
biocompatible characteristics 14-16. Biocompatibility is one of the most critical factors 
when considering a material for clinical use17. For this reason, investigators have sought 
a tissue matrix that could naturally interface with host tissues with minimal host 
response18-21.  
 
An ideal biomaterial for abdominal wall repair should be biocompatible and non-
immunogenic. It should also be able to promote the formation of new tissue through 
cellular ingrowth and be able to withstand the tensile forces created by the abdominal 
viscera and maintain structural integrity 2,3,15. Because acellular human dermis appears 
to possess these characteristics, it has been evaluated as a material for abdominal wall 
repair.  FlexHD Acellular Dermis and FlexHD Acellular Dermis-THICK are matrices that 
are naturally derived, biodegradable, and primarily composed of collagen from human 
skin. Both materials were developed as biomaterials for surgical fascial replacement 
and have good tissue handling characteristics22. While there is a commercially available 
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product (AlloDerm®) that originates from the same tissue source, the processing 
techniques distinguish these materials from each other. 
 
AlloDerm® is an acellular dermal matrix prepared from human skin. Skin is procured 
from cadaveric donors and aseptically processed to remove the epidermis. A 
hyperosmolar sodium chloride solution is used to separate the dermal and epidermal 
layers. Sodium deoxycholate is then utilized for cell removal. The acellular dermis is 
cryoprotected prior to freeze drying and packaging, leaving an intact matrix with 
basement membrane components23 . AlloDerm has been reported to be a suitable 
biomaterial in several clinical applications, including abdominal wall repair23-27 and 
breast reconstruction28. 
 
The present study was designed to assess the biocompatibility and feasibility of using 
this type of acellular dermis matrix as a fascial tissue substitute for abdominal wall 
repair. The objectives of this study were to test the ability of acellular dermal matrix to 
support tissue formation in the abdomen and to determine the utility of acellular dermis 
as a biocompatible fascial tissue substitute for abdominal wall repair. We examined 
whether acellular dermis provides adequate support and strength for in vivo abdominal 
applications. 
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MATERIAL AND METHODS 
Human Dermis Preparation  
Flex HD Acellular Dermis (group I) and FlexHD Acellular Dermis-THICK (group II) are 
derived from human allograft skin that is processed using proprietary procedures 
developed by MTF (Musculoskeletal Transplant Foundation, Edison, NJ). Prior to tissue 
harvest, the donor’s medical and social histories are screened for any abnormal medical 
pathology, disease processes and other pertinent information that would cause the 
donor to be unsuitable for human transplant.  The screening process is completed by 
the MTF’s highly trained National On-Call Coordinators using the strict standards 
developed by the MTF Medical Board of Trustees. Donors are screened for a series of 
diseases including, but not limited to, HIV, HTLV I and II, hepatitis B and C and syphilis. 
MTF donor screening procedures and serologic and microbiologic testing policies meet 
current established industry standards. At MTF, skin is processed aseptically in a 
controlled clean room environment that meets current AATB standards 29.  
 
Donor skin grafts are decellularized to reduce the occurrence of adverse immune 
responses in graft recipients 30,31. This decellularization procedure involves a series of 
soaks and water rinses performed under gentle agitation. The tissue is first soaked 
overnight at ambient temperature in a hypertonic, 1M sodium chloride solution, followed 
by water rinses. The skin is then soaked in 0.1% Triton X-100 non-ionic detergent to 
remove cellular fragments. A thorough water rinse is then performed to remove 
detergent residuals from the tissue. A residual detergent test using Gas 
Chromatography - Mass Spectrometry (GC-MS) and High Pressure Liquid 
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Chromatography (HPLC) is performed to ensure detergent levels are sufficiently low. 
The measured concentration of sodium chloride and Triton X-100 must be lower then 10 
PPM. The acellular dermis is then subjected to a disinfection process in a solution 
containing alcohol, peracetic acid  [less than 1% (v/v), prepared from 35-40% stock 
solution], and propylene glycol. The matrix is gently agitated under vacuum and then 
rinsed with sterile water. Residual analysis of reagents used in the preparation of 
acellular dermis are then performed using GC-MS and HPLC to confirm that residuals 
are below established safety limits (0.001%). Matrix integrity is assessed throughout 
processing using light and electron microscopy to verify normal collagen bundle 
patterns and macroscopic collagen matrix structure, as well as to confirm the removal of 
cellular material. Following disinfection, the dermal matrices are immersed in 70% 
ethanol solution and packaged in a sterile impermeable pouch.  The biomaterials are 
tested for sterility in accordance with procedures in the current United States 
Pharmacopeia (USP) 32.  
 
The MTF dermal disinfection process has been validated to demonstrate a six log 
reduction in a panel of microorganisms most commonly found in the body or on the skin. 
These include Escherichia coli, Candida albicans, Staphylococcus aureus, 
Staphylococcus epidermis, Pseudomonas aeruginosa, Bacillus subtillis, Clostridium 
sporogenes and Streptococcus pyogenes. In addition to its effectiveness for bacterial 
inactivation, this process has been demonstrated to be effective for inactivation of 
certain viruses. The decontamination process was evaluated in accordance with the 
International Conference on Harmonization for Viral Clearance Studies of Biotechnology 
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Products. Studies established that this decontamination process was effective in 
inactivation of human immunodeficiency virus type I (HIV-I), human hepatitis A virus 
(HAV), porcine parvovirus (PPV) as a model for human parvovirus B19 (HPV), human 
polio virus, bovine viral diarrhea virus (BVDV) as a model for human hepatitis C virus 
(HCV), and pseudorabies virus (PrV) as a model for human cytomegalo (CMV) herpes 
virus.  
 
Furthermore, the safety and biocompatibility of acellular dermis prepared following 
these procedures is evaluated using a test strategy developed in accordance with ISO 
10993, Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing and 
the FDA G95-1 Memorandum that guides the use of this international standard.  
Acellular dermis is evaluated in consideration of the biomaterial as an implant with 
contact to tissue. Tests include evaluation of cytotoxicity, sensitization, irritation, acute 
systemic toxicity, material-mediated pyrogenicity, genotoxicity, implantation, chronic 
toxicity, and carcinogenicity. Test results indicate that acellular dermis is non-cytotoxic, 
not a sensitizer, not an acute toxin, and non-pyrogenic. Genotoxicity studies indicated 
that extracts of acellular dermis were non-clastogenic in the Chinese hamster ovary in 
vitro test system and in the in vivo Mouse Micronucleus test and were non-mutagenic in 
the Ames bacterial test system. 
 
The main difference between the FlexHD Dermis and Dermis-THICK grafts is, as the 
name implies, the thickness. Human Dermis (group I) consists of the dermal layer of 
human skin and has a median thickness of 0.45±0.15 mm. The FlexHD Dermis-THICK 
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(group II) consists of human dermis and parts of the hypodermis, and has a median 
thickness of 1.0±0.5 mm.  The AlloDerm® (LifeCell Corporation, Branchburg, NJ) used 
in this study is commercially available. The material thickness ranges from 1.8 mm to 
3.3 mm according to the package labeling. 
 
Biomaterial characterization and ultra structure 
Prior to in vivo implantation all 3 biomaterials were analyzed using scanning electron 
microscopy (SEM). For ultrastructural analysis, the biomaterials were placed in PBS 
and frozen at -80 OC. After lyophilisation under vacuum, the samples were sputtered 
using a gold platinum target and analyzed using a scanning electron microscope at 
various magnifications. Morphometric analysis was performed to evaluate the pore size 
by measuring 15 random pores. In oval shaped pores the smaller diameter was 
recorded. Further, pepsin-soluble collagen was measured by collagen assay and 
biomechanical testing was performed (see below).  
Animal Model 
The animal study was performed in accordance with the Animal Care and Use 
Committee (ACUC) at Wake Forest University. A total of 48 New Zealand White rabbits 
weighing approximately 3 kg were randomized into 4 groups (Table 1): Group I animals 
received FlexHD Acellular Dermis grafts and group II animals received FlexHD Acellular 
Dermis-THICK grafts. Two control groups were used. In Group III, the commercial 
product AlloDerm® was used, and in group IV a sham operation was performed. Four 
animals from each group were sacrificed at 6, 12 and 24 weeks after implantation. 
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Surgery Preparation and Anesthesia  
The animals were sedated with an intramuscular injection of 35 mg/kg ketamine and 
5mg/kg xylazine. The animals were intubated and anesthesia was maintained with 2% 
to 3% isoflurane. One milliliter of blood was drawn for analysis (hematogram) prior to 
graft implantation and at the time of sacrifice. All animals received a single dose of 
antibiotics (Enrofloxacin 2.5 mg/kg). The surgical site was shaved and prepped in a 
sterile manner. The animals were placed in the supine position. 
Abdominal Surgery  
A midline abdominal incision was made and the subcutaneous tissue layer on the left 
side of the abdomen was bluntly dissected. A 4 x 6 cm defect was created by excising a 
full thickness portion of the abdominal wall. Care was taken not to harm internal organs. 
All biomaterials were soaked for 10 minutes in normal saline followed by a soak in 0.1% 
gentamicin solution for 10 minutes, after which the material was trimmed to fit the 
defect.The biomaterial was sutured to the abdominal musculature with 3-0 Prolene 
(non-absorbable) running sutures and the exact size was measured and recorded. 
The sham operation included a midline abdominal incision with dissection of the same 
subcutaneous layers, but without removal of tissue. The abdomen was then closed with 
3-0 Prolene sutures in a running fashion. The wound closure was performed in a 
running fashion with subcutaneous 3-0 Vicryl (absorbable) and 3-0 PDS (absorbable) 
sutures for the skin.  
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Postoperative Care 
At the end of the procedure, the animals were extubated and transferred to the 
postoperative care unit. All animals were closely observed for at least 4 hours until fully 
awake. An intramuscular dose of buprenorphine (0.02 mg/kg) was given every 12 hours 
for the first 72 hours post-operatively, and as needed thereafter. Fecal and urinary 
output were monitored and recorded. 
Implant retrieval and gross examination   
Immediately after euthanasia, the implant site was inspected. Parameters assessed via 
gross examination included hernia formation, size and integration of the biomaterial into 
surrounding connective tissue. The sites were also inspected for evidence of fibrosis, 
infection and inflammatory responses. The dimensions of each biomaterial segment 
were measured and the average change was expressed as a percent of the original 
size. The size of the biomaterials prior to surgery was defined as 100%.  
Measurements of abdominal bulging and hernia formation were made after euthanasia, 
with the abdomen still closed, by laying the animal in supine position and gently 
pressing on the abdominal wall surrounding the implant. Any extrusion of the abdomen 
with significant ballooning of greater than 3cm was recorded as bulging. Hernia was 
defined as macroscopic rupture of the biomaterial at the time of retrieval.  
The implanted biomaterials were harvested through a midline incision. To reduce the 
risk of perforation of the implanted grafts, the abdomen was opened with an incision 
through the rectus muscle on the opposite side. Adhesion to the biomaterial was scored 
for extent (%) using the Modified Diamond Scale (0 = 0%, 1 <or= 25%, 2 = 25-50%, 3 > 
50%)33. After assessing the levels of adherence, the biomaterial was freed from the 
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surrounding tissues. The entire implant was removed en bloc and measured. The 
harvested biomaterial was cut into separate segments for histology, biomechanical 
studies, collagen assay and storage at -80 OC. A 5 x 6 cm piece of the abdominal 
muscle was harvested from the sham operated animals as a normal control.  
 
Abdominogram 
Abdominograms were performed by injecting 20 ml of contrast media (Optiray 240, 
Malinckrodt Inc, St. Louis, MO) into the abdominal cavity at the time of sacrifice. After 
waiting for several minutes for the contrast media to collect at the site of the hernia 
repair, lateral radiography was performed (Siemens Siremobil compact L, Germany). 
Histology  
The retrieved tissue specimens were fixed in 10% neutral formalin for 12 hours. All 
specimens were rinsed 3 times in PBS and placed in the tissue processor (Citadel 
1000, Thermo-Shandon). Five micron thick sections were obtained from the paraffin 
embedded blocks (RM2145, Leica).  Some sections were stained using hematoxylin 
and eosin (H&E), a staining method widely used for the assessment of local 
inflammatory response. Furthermore, Masson’s Trichrome staining was used to assess 
collagen deposition. For each group, evidence of inflammatory response and quality of 
the collagen layer were noted. No quantitative analyses were performed.  
Biomechanical Studies  
Rectangular tissue strips (50 mm x 10 mm) were obtained from the abdominal hernia 
repairs. Strips of native abdominis externus fascia of equal size were used in the sham 
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group (normal control). Tensile tests (Instron model 5544 with 2716-016-1kn Grips, 
Norwood, MA, USA) were performed by elongating the tissue strips longitudinally at a 
speed of 0.05 mm/second with a preload of 0.2 N until failure. The grip-to-grip spacing 
was 2 cm. All specimens were tested at room temperature and kept moist. The 
maximum tensile strain and stress forces were determined. For the determination of 
strain the grip to grip distance was taken into account. The results of the 6, 12 and 24 
weeks time points were analyzed. 
 
Collagen Assay 
Two rectangular pieces of the biomaterial (5mm x 5mm) from each animal were used to 
quantify the pepsin-soluble collagen fraction. This is a well established assay to define 
the amount of newly produced collagen present in a sample 34,35. Both samples were 
taken 1 cm from the suture line. Fat and peritoneal layers were carefully removed and 
the samples weighed. All samples were placed in 0.5 N acetic acid containing 1 mg 
pepsin per 10 mg tissue. Samples were kept on an orbital shaker for 12 hours. After 
centrifugation at 2000g for 10 minutes, 100 µl supernatant was assayed using a kit 
according to the manufacturer’s protocol (Sircol, Biocolor Ldt,. Newtownaffey, Ireland).  
Briefly, 1ml of Sircol dye reagent was added and the samples were mixed for 30 
minutes. After centrifugation, the pellet was suspended in 1 ml of alkali reagent included 
in the kit and read at 540 nm with a spectrophotometer. Standards were produced using 
the collagen supplied in the kit. The results were expressed as µg collagen per mg of 
biomaterial (wet weight). 
Statistical Analysis 
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All numerical data are expressed as averages and the corresponding standard error of 
the mean (SEM). For statistical analysis we used SPSS v11 (SPSS Inc). Differences 
between the groups and different time points were analyzed by one-way analysis of 
variance (ANOVA) followed by a Bonferroni test for multiple comparisons. A p value of 
less than 0.05 was considered significant.     
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Results  
Characterization and ultra structure of the biomaterials 
The ultrastructural analysis with SEM demonstrated a distinct difference between the 
biomaterials (Figure 1). FlexHD Acellular Dermis showed a layered structure with dense 
protein layers. The FlexHD Acellular Dermis-THICK demonstrated large pores 
throughout the biomaterial and the layering was partially interrupted. AlloDerm® showed 
distinct layering of protein dense structures, with few pores connecting the layers. The 
morphometric measurement of the pore size found similar widths for all materials (9.7 ± 
1.0 µm for the FlexHD Acellular Dermis, 24.8 ± 2.9 µm for the FlexHD Acellular Dermis-
THICK and 17.8 ± 1.4 µm for the AlloDerm®).  
In summary, the layering was most dominant in AlloDerm ® (AlloDerm ® > FlexHD 
Acellular Dermis > FlexHD Acellular Dermis-THICK). The thickness of the biomaterial 
and the pore diameter was the largest for FlexHD Acellular Dermis-THICK (FlexHD 
Acellular Dermis – Thick > AlloDerm ®> FlexHD Acellular Dermis). All 3 biomaterials 
consisted mainly of mature collagen fibers. The level of pepsin soluble pre-collagen 
remained consistently low with values of 0.5 ± 0.1 µg/mg for FlexHD Acellular Dermis, 
0.5 ± 0.1 µg/mg  for FlexHD Acellular Dermis–THICK and 0.6 ± 0.2 µg/mg  for 
AlloDerm® (see also collagen assay below). 
In Vivo Animal Studies 
There were no surgical complications or postoperative problems. One animal expired 
during intubation and was replaced immediately with a new rabbit, since this death was 
unrelated to the study.  
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Gross examination   
The implants and the surrounding tissues were inspected grossly after euthanasia 
(Figure 2). There were no hernias observed at the time of retrieval in any of the groups. 
However, bulging of the biomaterial without tearing was observed in all groups but 
sham. The FlexHD Acellular Dermis group contained 6/16 animals with bulging (2 at 6 
weeks, 2 at 12 weeks and 2 at 24 weeks), the FlexHD Acellular Dermis-THICK group 
had 5/16 (2 at 12 weeks and 3 at 24 weeks) and the AlloDerm® Group had 3/16 (3 at 
24 weeks). The exact size of the biomaterial was measured at the time of implantation 
and at sacrifice. All biomaterials used in this study showed a distention of approximately 
200% at 24 weeks (Figure 4). The exact measurements for FlexHD Acellular Dermis at 
6, 12 and 24 weeks were 179.8 ± 27.8%, 208.0 ± 33.7% and 217.0 ± 20.9%, for FlexHD 
Acellular Dermis-THICK160.1 ± 10.8%, 200.3 ± 20.2% and 200.8 ± 23.5%, and for 
AlloDerm® 140.7 ± 2.5%, 151.5 ± 16.4% and 209.7 ± 32.9%. 
Further, none of the animals developed bowel adhesions to the biomaterial. 
Occasionally, a small adhesion to the suture material (PDS 4-0) was seen and bluntly 
dissected.  
Gross examination of the retrieved tissues 6 weeks after implantation was similar for all 
3 biomaterials. All acellular grafts showed evidence of early vascularization with visible 
blood vessels on the peritoneal side of the biomaterial. There were no signs of 
inflammation, infection or fibrosis and the biomaterials were stably embedded into the 
host subcutaneous tissues. Further, no seromas or shrinkage of the biomaterials were 
recorded. One animal from the FlexHD Acellular Dermis group showed the formation of 
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a small nodule. A small biopsy of this nodule was sent off for bacteriological 
examination, but was negative for both aerobic and anaerobic bacterial growth.  
At 12 weeks after implantation, the biomaterials were well integrated into the abdominal 
wall and the subcutaneous tissue. At this time, some biomaterials showed signs of 
thinning, becoming more transparent compared to the starting material.  These 
transparent areas were framed by fibrous connective tissue. In the FlexHD Acellular 
Dermis all implantations showed some thinning. In the FlexHD Acellular Dermis-THICK 
group, only one biomaterial showed this thinning. In the AlloDerm® group, the 
biomaterials from 3 animals showed the formation of thin, transparent areas between 
fibous connective tissue. 
This thinning was more prominent at 24 weeks (Figure 3) and some of the samples had 
the appearance of a thick spider web. In the FlexHD Acellular Dermis group, 3 out of 4 
samples were very thin, and in the FlexHD Acellular Dermis-THICK group 2/4 implants 
demonstrated this thinning. All AlloDerm® implants had some thin areas with sparse 
collagen fibers, but the AlloDerm® implants appeared thicker than the implants from the 
other groups. One animal from the Alloderm® group showed signs of calcification within 
the biomaterial. The sham operated group showed a tight wound closure with no sign of 
inflammation at the suture line after 6, 12 and 24 weeks of implantation.  
 
Blood Analysis 
Blood analysis was performed prior to implantation and at the time of sacrifice. The 
white blood counts (WBC) before implantation and at 6, 12 and 24 weeks were all within 
the rage of healthy animals. None of the animals showed a significant rise of WBC 
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(>30%) commonly seen during stress or infection36. This indicates that there is no 
systemic reaction to any of the biomaterials used. 
 
Abdominogram 
Abdominograms were performed in 2 random cases for each experimental group at 
each time point. No contrast media leakage into the abdominal tissue or herniation was 
observed in the studied animals. All groups showed a smooth contour of the peritoneal 
tissue layer without signs of bowel attachment. 
 
Histology  
Hematoxylin and Eosin and Trichrome staining were performed on tissue from each 
group. The matrix structure was intact in all groups at all time points. FlexHD Acellular 
Dermis, FlexHD Acellular Dermis-THICK and AlloDerm® implants showed longitudinal 
collagen bundles, parallel to the tension lines of the abdominal wall, at all time points 
(Figure 5). Histologically, the appearance of the collagen bundles did not change during 
the entire study period (Figure 6). No lymph follicle formation was present in any of the 
abdominal graft samples. The findings in the sham animals were unremarkable, and 
included a low grade inflammatory response and some fatty degeneration of the muscle 
along the suture line. 
At the 6 week time point, the FlexHD Acellular Dermis group showed an inflammatory 
response characterized by an infiltration of host cells that appeared to be lymphocytic in 
nature. The inflammatory cells were concentrated at the interface of biomaterial and 
muscle. FlexHD Acellular Dermis, FlexHD Acellular Dermis-THICK and AlloDerm® 
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implants showed extensive neovascularization with small blood vessels on the 
abdominal side of the biomaterial. At 12 weeks, cellular infiltration into the middle 
biomaterial was complete and blood vessels found in the material were larger than 
those observed at 6 weeks. There were no cell-free patches within the biomaterial. At 
12 weeks a shift from inflammatory cells towards the presence of spindle shaped 
fibroblasts was evident, when compared to 6 weeks. At 24 weeks, a well organized 
fibroblastic ingrowth was present and new tissue formation was seen.  
The findings in the FlexHD Acellular Dermis-THICK group were very similar. An early 
inflammatory response in the interface regions could be seen. Complete cellular 
penetration and the appearance of aligned, spindle shaped cells were observed after 12 
weeks. The histology at 24 weeks closely resembled the findings of native external 
abdominal aponeurosis. 
Alloderm ® demonstrated a rapid infiltration of host cells from the suture line at 6 weeks. 
However, the central regions of the implanted material remained free of cells for more 
than 12 weeks. At 24 weeks, the levels of cellular penetration were comparable to the 
FlexHD groups. Further, the spindle shaped cells present within longitudinal bundles of 
collagen were aligned similar to normal fascia.  
In summary, all three biomaterials showed a mildly inflammatory, wound healing 
response at 6 weeks. The levels of neovascularization were comparable for all 
materials. Ingrowth of cells and infiltration of spindle shaped cells were greater for 
FlexHD Acellular Dermis and FlexHD Acellular Dermis-THICK group. AlloDerm ® had 
cell free areas for over 12 weeks. However, the final outcome was very similar after 24 
weeks.    
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Biomechanical Studies  
The biomechanical characteristics of the investigated biomaterials were measured at 6, 
12 and 24 weeks and compared to native abdominal fascia (Figure 7). FlexHD Acellular 
Dermis and FlexHD Acellular Dermis-THICK grafts demonstrated a decrease in 
maximal tensile stress (MPa) from 6 to 12 weeks followed by a significant increase in 
strength from 12 to 24 weeks. At that time, values similar to native fascia were 
observed. AlloDerm ®, on the contrary, was stronger at the start of the experiment but 
gradually showed a sustained loss of maximal tensile strength over time.  
The maximal strain at rupture showed values that are comparable to native connective 
tissue for all biomaterials. The strain of FlexHD Acellular Dermis decreased from 6 to 12 
weeks and regained normal values at 24 weeks. Both the FlexHD Acellular Dermis-
THICK graft and AlloDerm® began with a higher strain than normal tissue at 6 weeks, 
which decreased in a linear fashion over time. However, both materials remained within 
an acceptable range of strain values during the study period.  
The Young's modulus (E), a measure of the stiffness of a given material, was used to 
evaluate the elastic modulus of the biomaterials at 6, 12 and 24 weeks. All sampled 
tissues were within the range of native soft tissue. Both FlexHD Acellular Dermis grafts 
showed a loss of modulus from 6 to 12 weeks, but the values increased to normal 
values from 12 to 24 weeks. AlloDerm ® showed a loss in modulus over time, but still 
remained close to native controls.  
 
Collagen Assay 
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Quantification of newly synthesized collagen was performed using a pepsin-soluble 
collagen assay. This assay is able to quantify the cumulative synthesis of new collagen 
within the biomaterial37,38. All investigated biomaterials harbored cells that produced 
new collagen.  A 6-fold increase was observed at 24 weeks (Figure 4). In the FlexHD 
Acellular Dermis group, production of collagen remained low until 12 weeks. However, 
at 24 weeks, production of collagen by ingrown cells was similar to the other groups. 
The FlexHD Acellular Dermis-THICK showed a 2-3 fold increase in the newly formed 
collagen at 6 and 12 weeks, while the AlloDerm® showed a 3 fold increase at 6 and 12 
weeks. At 24 weeks, all biomaterials showed similar amounts of newly produced 
collagen. There were no statistical significant differences between the groups.  
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Discussion 
The current standard for abdominal hernia repair is the use of a propylene mesh. 
However, this non-absorbable biomaterial is known to induce the formation of a fibrotic 
capsule through overproduction of collagen by infiltrating fibroblasts. Although this 
response can successfully repair a hernia, many patients report discomfort due to its 
stiffness 39. Acellular biomaterials derived from tissues have been suggested as an 
alternative to polypropylene mesh in abdominal fascial repair surgery. These materials 
have been shown to have excellent biocompatibility in other systems 3,17,18,20,40. They 
appear to allow for cellular ingrowth and new tissue formation while maintaining 
biomechanical properties similar to native connective tissue 1,14,18,41.  The findings 
presented here show that acellular biomaterials derived from human dermis meet the 
requirements needed for successful hernia repair. Biocompatibility was assessed in 
several ways, including gross examination of the biomaterial at retrieval, microscopic 
evaluation and testing for systemic response.  
 
Further, the tissue handling and surgical characteristics were excellent as the 
biomaterials remained soft and malleable throughout the study period. The aims of this 
study were to investigate the ability of acellular dermal matrix to support tissue 
formation in the abdomen and to determine the utility of acellular dermis as a 
biocompatible fascial tissue substitute for abdominal wall repair. We compared two new 
acellular human dermis preparations (FlexHD and FlexHD-THICK) with a commercially 
available product (AlloDerm®). Although the origin of these biomaterials is the same, 
there are some distinct differences in the processing techniques used to obtain them. 
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While FlexHD is decellularized by a commonly used non-ionic detergent (Triton-X), 
LifeCell Inc. uses deoxycholic acid and EDTA. Further, FlexHD is decontaminated using 
an oxidative treatment alone (peracetic acid <1%), while AlloDerm® might contain 
residual gentamicin, cefoxitin, lincomycin, polymyxin B and vancomycin from different 
decontaminating washes, and these may potentially trigger an allergic reaction after 
implantation42-45. Lastly, for packaging and storage, AlloDerm ® is freeze-dried and 
requires refrigeration, but FlexHD is soaked in ethanol before packaging and has a shelf 
life of 3 years at room temperature (Alloderm product information sheet, USFDA). This 
difference is important, because recent research has shown that dried acellular 
biomaterials may not perform as well in terms of cellular attachment and growth, which 
may be due to a change in ultrastructural morphology 46. 
Despite these differences, all dermis implants showed regional tissue formation with 
fibroblastic infiltration, which developed an alignment parallel to the tension lines of the 
abdominal wall. However, there was no layering according to normal anatomy. Further, 
none of the biomaterials induced bowel adhesions, which are commonly seen when 
synthetic biomaterials are used 47-51. Collagen assays indicated that synthesis of new 
collagen fibers occurred within the biomaterials. This could be one possible explanation 
for the increased strength of the biomaterials after 12 weeks.  
Microscopically, all biomaterials showed penetration of inflammatory cells and spindle 
shaped fibroblasts. At 12 weeks, cellular infiltration into the middle of the biomaterial 
was complete in both FlexHD grafts, while AlloDerm® still contained some cell-free 
regions between dense collagen bundles. Accelerated cell penetration could be 
beneficial, as it could decrease the risk of postoperative infection of the biomaterial and 
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expedite remodeling. On the other hand, this might lead to an early loss of strength 
through increased degradation of the biomaterial. However, at 24 weeks, there was no 
difference in cellularity, alignment of fibroblasts or vascularity between the study groups.  
 One key to a successful abdominal hernia repair is the selection of an appropriate 
biomaterial that can withstand changing forces, such as those that may occur during 
sneezing or coughing. In this regard, all of the biomaterials studied possess the 
necessary strain characteristics for a fascial substitute7,52-54. None of the animals 
included in this study developed hernias. However, all groups contained some animals 
in which bulging of the biomaterial was evident. This is probably due to degradation of 
the biomaterial after implantation and the high variability of the structure of naturally 
derived biomaterials.  This could result in weak areas of the material which stretch over 
time. The excised area corresponds to the replacement of approximately 1/4 of the 
abdominal wall by a biomaterial. Further, the horizontal orientation of the body axis 
maximizes the pressure on the implanted biomaterial. Taken together, the extension of 
the biomaterials to approximately 200% at 24 weeks without rupture is promising. The 
use of multiple layers of an acellular biomaterial may reduce variability and improve the 
strength of the material.  
In this study we have applied a large piece of biomaterial, which may raise concerns 
that such a large amount of matrix may lead to untoward systemic effects55,56. We have 
assessed the systemic response by evaluating the complete blood counts (CBC) and 
differentials. None of the animals showed significant changes due to the implantation of 
the biomaterial. Therefore, a systemic effect of acellular biomaterials derived from 
human dermis can be ruled out.  
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Summary 
FlexHD Acellular Dermis, FlexHD Acellular Dermis – Thick, and AlloDerm ® maintained 
their strength in the rabbit hernia repair model with no incidence of hernia formation and 
no bowel adhesion. Macroscopic and microscopic evaluation showed excellent 
integration, tissue formation and production of new collagen in the biomaterials. We 
conclude that FlexHD Acellular Dermis, FlexHD Acellular Dermis – Thick, and 
AlloDerm®, which are derived from human dermis, are suitable biomaterials for 
abdominal hernia repair.   
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Legends 
 
Figure 1. Biomaterial Ultrastructure: Scanning Electron Microscopy of FlexHD 
Acellular Dermis (A, D, G), FlexHD Acellular Dermis-THICK (B, E, H) and AlloDerm® 
(C, F, I). 
The surface of the biomaterials (A-C), sale bar represents 200µm. FlexHD Acellular 
Dermis and Alloderm® show strong collagen layers without significant pores throughout 
the material. FlexHD Acellular Dermis-THICK graft shows many pores penetrating the 
biomaterials top layer. Side view of the biomaterials (D-F), scale bar represents 500 µm. 
The difference in thickness is clearly visible (arrows). Further, FlexHD Acellular Dermis 
and AlloDerm ® show a strict orientation of the collagen layers, this layering is less strict 
in FlexHD Acellular Dermis-THICK grafts. Higher magnification of side view, scale bar 
represents 50 µm (G-I), showing the different pore size, orientation and thickness of 
collagen fibers.  
 
Figure 2. Gross Examination. Macroscopic view of the implants at retrieval after 
removal of the dermal and fat layer at 24 weeks. A- FlexHD Acellular Dermis, B- FlexHD 
Acellular Dermis-THICK, C- AlloDerm ®, D- Sham operation. White dots indicate the 
corners of the biomaterial.  
 
Figure 3: Gross Examination, peritoneal side. Direct macroscopic view of the 
peritoneal side of the biomaterial at 24 weeks showing the thinning areas surrounded by 
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thicker collagen bundles. A- FlexHD Acellular Dermis, B- FlexHD Acellular Dermis-
THICK, C- AlloDerm ®, 
 
Figure 4: Size of Biomaterial and Collagen Assay  
A) All biomaterials showed a relaxation to aprox. 200% at 24 weeks. AlloDerm® showed 
less distention at 6 and 12 weeks. However, at 24 weeks the expansion was 
comparable to FlexHD Acellular Dermis Grafts. B) All biomaterials showed the synthesis 
of new pepsin-soluble collagen through ingrown cells. Compared to FlexHD Acellular 
Dermis-THICK and AlloDerm®, FlexHD Acellular Dermis was lagging in collagen 
production at 6 and 12 weeks (p=0.031). However, at 24 weeks the amount of newly 
formed collagen was similar in all groups. The asterisk indicates a statistically significant 
difference between groups. 
 
Figure 5: Histology. Hematoxilin and Eosin (12 Weeks). 
The histology shows a mixed cell infiltration and areas with beginning fibroblastic 
alignment (arrows) in all biomaterials. There were no signs of infection or severe 
inflammation. A- FlexHD Acellular Dermis, B- FlexHD Acellular Dermis-THICK, C- 
AlloDerm ®, D- Sham operation. All images reduced from 100x 
 
Figure 6. Histology. Trichrome Stain (12 weeks).  
The collagen bundles (blue) remained intact throughout the duration of the study in all 
biomaterials. A- FlexHD Acellular Dermis, B- FlexHD Acellular Dermis-THICK, C- 
AlloDerm ®, D- Sham operation. All images reduced from 100x 
  Page 28
 
Figure 7. Biomechanical Studies 
A) Maximal tensile stress (MPa) at 6, 12 and 24 weeks demonstrating the loss and 
regain of tensile stress for FlexHD Acellular Dermis Grafts. AlloDerm® lost maximal 
tensile stress over time. At 12 weeks the differences were significant when compared to 
normal, FlexHD Acellular Dermis p>0.001, FlexHD Acellular Dermis-THICK p=0.001 
and AlloDerm® p=0.023. There was no significant difference between the 3 
biomaterials.  (B) The analysis of the maximum strain at rupture showed values well 
within the range of native soft tissues at all time points. There was a trend towards loss 
of strain over time for FlexHD Acellular Dermis-THICK and AlloDerm®. FlexHD Acellular 
Dermis shows a loss and regain of strain over the study period. C) The modulus, a 
measure for the stiffness of a material, demonstrated a continuous loss for AlloDerm ® 
and a reduction and regain of modulus for FlexHD Acellular Dermis Grafts. At 12 week 
only FlexHD Acellular Dermis-THICK was significantly different when compared to 
normal fascia, p=0.009. All values are compared to native fascia indicated as normal (2x 
SEM, standard error of the mean). The asterisk indicates a statistically significant 
difference between experimental and normal fascia groups.  Values for native fascia are 
shown in the graphs as gray bars labeled with “normal” (2x SEM).  
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